Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Long-term, Phase 3 Study to Evaluate the Safety and Efficacy of TVP-1012 at 1 mg in Levodopa Treated Parkinson's Disease Patients

NCT02337764 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02337764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02337764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Long-term, Phase 3 Study to Evaluate the Safety and Efficacy of TVP-1012 at 1 mg in Levodopa Treated Parkinson's Disease Patients
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
February 3, 2015
Completion date
September 29, 2016
Enrollment
222 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease